<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02803385</url>
  </required_header>
  <id_info>
    <org_study_id>1681</org_study_id>
    <nct_id>NCT02803385</nct_id>
  </id_info>
  <brief_title>Comparison of Patient Controlled &amp; Continuous Epidural Analgesia in Thoraco-abdominal Surgeries in Cancer Patients</brief_title>
  <official_title>Comparison of Efficacy of Patient Controlled Epidural Analgesia Versus Continuous Epidural Infusion Following Thoraco-abdominal Surgeries in Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tata Memorial Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tata Memorial Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the efficacy of pain control, the consumption of local anesthetic&#xD;
      and opioids, side effects, and patient satisfaction between continuous epidural infusion and&#xD;
      patient controlled epidural analgesia after thoraco-abdominal surgeries in cancer patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim-&#xD;
&#xD;
        1. To compare the pain scores during rest and movement with continuous epidural infusion&#xD;
           (CEI) vs. patient controlled epidural analgesia (PCEA)&#xD;
&#xD;
        2. To compare the incidence of side effects between 2 groups&#xD;
&#xD;
        3. Comparison of local anaesthetic and opioids requirement by PCA attempts and also rescue&#xD;
           analgesia requirement.&#xD;
&#xD;
        4. To compare patient satisfaction with the two different modalities of pain management&#xD;
&#xD;
      Sample size- Based on our hospital data for postoperative pain management after&#xD;
      thoraco-abdominal surgeries, it was found that 69.7 % patients experience moderate to severe&#xD;
      pain (pain score 4-10) on first day postoperatively.&#xD;
&#xD;
      Considering a 50% reduction as meaningful, group sample size of 62 with 31 in each group was&#xD;
      calculated using a chi square test. Assuming a 10% loss to follow up or drop outs from study&#xD;
      we require 35 in each group with total sample size of 70.&#xD;
&#xD;
      Variables- age, sex, demographic factors, surgery, duration of surgery, pain score, nausea&#xD;
      score, hypotension episode, pruritis, Vomiting episode, patients satisfaction score,&#xD;
      requirement of rescue analgesia.&#xD;
&#xD;
      Analysis of variables:&#xD;
&#xD;
      Descriptive statistics will be used for data representation. The Ï‡2 and Fisher's exact&#xD;
      probability tests will be used to analyze the differences between qualitative data.&#xD;
      Comparisons of two groups will be analyzed using the Independent sample t test or&#xD;
      Mann-Whitney U test as per the distribution of data. A P-value less than 0.05 will be&#xD;
      considered statistically significant. Patient satisfaction using verbal rating scale will be&#xD;
      analysed using Mann-Whitney U test.&#xD;
&#xD;
      Methodology- Patient meeting inclusion criteria, 4 hours after surgery will be reassessed in&#xD;
      absence of any post-operative exclusion criteria, patient will be randomized into either&#xD;
      group as per a computer generated chart and study will start from this time.&#xD;
&#xD;
      Postoperative group A will receive continuous epidural infusion at rate of 5-8 ml /hr based&#xD;
      on maximum allowable safe dose as per body weight[10]. The Patient Controlled Analgesia&#xD;
      settings will be set at 0.1 ml per bolus with lockout interval of 20 minutes.&#xD;
&#xD;
      Group B will receive patient controlled epidural analgesia in form of Patient Controlled&#xD;
      analgesia pumps with continuous rate of 5-8ml/hour &amp; demand dose of 2-3 ml p.r.n with a lock&#xD;
      out interval of 20 minutes based on maximum allowable safe dose as per body weight . Both the&#xD;
      groups will have a cross over at 36 hours postop.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Actual">January 2019</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the pain scores during rest and movement with continuous epidural infusion (CEI) vs. patient controlled epidural analgesia (PCEA)</measure>
    <time_frame>72 hours</time_frame>
    <description>pain scores to be assessed using Numerical Rating scale(1-10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare patient satisfaction between the two groups using Verbal Rating scale</measure>
    <time_frame>36 hours and 72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the incidence of side effects in both groups including hypotension, motor weakness, pruritus, nausea, vomiting and any other</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Continous Epidural Analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous epidural infusion at rate of 5-8 ml /hr based on maximum allowable safe dose as per body weight. The Patient Controlled Analgesia pump settings will be set at 0.1 ml per bolus with lockout interval of 20 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient Controlled Epidural Analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient controlled epidural analgesia in form of PCA pumps with continuous rate of 5-8ml/hour &amp; demand dose of 2-3 ml p.r.n with a lock out interval of 20 minutes based on maximum allowable safe dose as per body weight .</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Continous Epidural Analgesia</intervention_name>
    <description>continuous epidural infusion at rate of 5-8 ml /hr based on maximum allowable safe dose as per body weight. The pump settings will be set at 0.1 ml per bolus with lockout interval of 20 minutes. Cross over to other group will occur after 36hours.</description>
    <arm_group_label>Continous Epidural Analgesia</arm_group_label>
    <other_name>continous epidural infusion of local anesthetic with opioid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient Controlled Epidural Analgesia</intervention_name>
    <description>patient controlled epidural analgesia in form of Patient Controlled Analgesia pumps with continuous rate of 5-8ml/hour &amp; demand dose of 2-3 ml p.r.n with a lock out interval of 20 minutes based on maximum allowable safe dose as per body weight .The group will have a cross over at 36 hours postop.</description>
    <arm_group_label>Patient Controlled Epidural Analgesia</arm_group_label>
    <other_name>patient controlled boluses of local anesthetic with opioid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adult patients, American Society of Anaesthesia class I-II, posted for&#xD;
             thoraco-abdominal surgeries and planned for epidural catheter insertion for&#xD;
             perioperative pain management, will be included. The surgeries will include&#xD;
             gastrectomy, radical &amp; revision cholecystectomy, whipples procedure, pancreatectomy,&#xD;
             lobectomy, metastectomy, pneumonectomy will be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with contraindication to epidural catheter placement or use of opioids or&#xD;
             local anesthetic&#xD;
&#xD;
          2. Patients with contraindication to use of rescue analgesia like paracetamol and&#xD;
             diclofenac both in postoperative period&#xD;
&#xD;
          3. Multiple incision not covered with epidural like TTE, THE&#xD;
&#xD;
          4. Patients with failed epidural insertion&#xD;
&#xD;
          5. Patients with epidural band not covering the incision sites completely&#xD;
&#xD;
          6. Patient with hemodynamic instability leading to inability to use epidural within the&#xD;
             first 4-6 hours.&#xD;
&#xD;
          7. Patient shifted on ventilator or needing ventilator support the within first 6-12&#xD;
             hours.&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Parmanand Jain, MD, MNAMS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sumitra Bakshi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ankita Lapalikar, MBBS</last_name>
    <role>Study Chair</role>
    <affiliation>Student</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tata Memorial Hospital</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <results_reference>
    <citation>Liu SS, Allen HW, Olsson GL. Patient-controlled epidural analgesia with bupivacaine and fentanyl on hospital wards: prospective experience with 1,030 surgical patients. Anesthesiology. 1998 Mar;88(3):688-95.</citation>
    <PMID>9523813</PMID>
  </results_reference>
  <results_reference>
    <citation>Komatsu H, Matsumoto S, Mitsuhata H, Abe K, Toriyabe S. Comparison of patient-controlled epidural analgesia with and without background infusion after gastrectomy. Anesth Analg. 1998 Oct;87(4):907-10.</citation>
    <PMID>9768792</PMID>
  </results_reference>
  <results_reference>
    <citation>Standl T, Burmeister MA, Ohnesorge H, Wilhelm S, Striepke M, Gottschalk A, Horn EP, Schulte Am Esch J. Patient-controlled epidural analgesia reduces analgesic requirements compared to continuous epidural infusion after major abdominal surgery. Can J Anaesth. 2003 Mar;50(3):258-64.</citation>
    <PMID>12620949</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 8, 2016</study_first_submitted>
  <study_first_submitted_qc>June 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2016</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tata Memorial Centre</investigator_affiliation>
    <investigator_full_name>parmanand jain</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Patient Controlled Epidural Analgesia</keyword>
  <keyword>Continous Epidural Infusion Analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

